20
Participants
Start Date
November 30, 2011
Primary Completion Date
July 31, 2012
Study Completion Date
October 31, 2012
Zostavax vaccine
Commercially available Zostavax vaccine will be administered subcutaneously according to package insert guidelines. Each 0.65-mL dose contains a minimum of 19,400 PFU (plaque-forming units) of Oka/Merck strain of VZV.
Oklahoma Medical Research Foundation, Oklahoma City
Oklahoma Medical Research Foundation
OTHER